Prognostic factors for survival in a Chinese population presenting with advanced non-small cell lung cancer with an emphasis on smoking status: A regional, single-institution, retrospective analysis of 4552 patients

被引:5
|
作者
Hu, Qiong [1 ,2 ]
Li, Bing [1 ,2 ]
Garfield, David [3 ]
Ren, Shengxiang [1 ]
Li, Aiwu [1 ]
Chen, Xiaoxia [1 ]
Zhou, CaiCun [1 ,2 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai 200433, Peoples R China
[2] Tongji Univ, Sch Med, Inst Canc, Shanghai 200433, Peoples R China
[3] ProMed Canc Ctr, Shanghai, Peoples R China
关键词
age; histology; non-small cell lung cancer; prognostic factor; smoking status; NEVER-SMOKERS; CIGARETTE-SMOKING; HISTOLOGY; ADENOCARCINOMA; CHEMOTHERAPY; EPIDEMIOLOGY; COMORBIDITY; OUTCOMES; IMPACT; SEX;
D O I
10.1111/j.1759-7714.2011.00099.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lung cancer ranks as the top of cancer-related mortality in the world. Approximately 8590% of all lung cancer cases are non-small cell lung cancer (NSCLC). For advanced NSCLC patients, the five-year survival rate is less than 5%. Previous studies have attempted to determine prognostic factors, such as smoking status, gender, ethnicity, age, and histological type. However, the results are controversial and conflict. In this study, we investigated prognostic factors in a Chinese population presenting with advanced NSCLC. Methods: Medical records of patients with advanced NSCLC (AJCC Stage IIIB/IV) who received treatment at our institution were reviewed. Kaplan-Meier method and Cox Proportional Hazards model were performed in both univariate and multivariate analyses. Results: A total of 4552 patients were entered. Among them, 1320 (29.0%) were female, 2408 non-smokers (52.9%), and all had Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) = 0/1. Univariate analysis suggested that female gender (P < 0.001), adenocarcinoma histology (P < 0.001), age <70 (P < 0.001), and non-smoker status (P < 0.001) were associated with better survival. However, multivariate analysis demonstrated that age (hazard ratio [HR]= 1.173, 95% confidence interval [CI]: 1.0851.268, P < 0.001), smoking status (vs. non-smokers, HR = 1.212, 95% CI: 1.1231.308, P < 0.001), and histological type (non-adenocarcinoma vs. adenocarcinoma, HR = 1.104, 95% CI: 1.0311.181, P = 0.004), but not gender, were independent prognostic factors. Conclusions: Smoking status, age, and histological type are independent prognostic factors in Chinese NSCLC patients presenting with advanced disease. Non-smoking status is associated with better overall survival in Chinese NSCLC patients.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 50 条
  • [21] Smoking and Prognostic Factors in an Observational Setting in Patients with Advanced Non-Small Cell Lung Carcinoma
    Li, Chien-Te
    Marek, Magdalena
    Guclu, Salih Z.
    Kim, Younseup
    Meshref, Mohamed
    Qin, Shukui
    Kadziola, Zbigniew
    Krejcy, Kurt
    Altug, Sedat
    JOURNAL OF CANCER, 2011, 2 : 52 - U554
  • [22] Factors Associated With Survival in Patients With Non-small Cell Lung Cancer from a Single Institution Study of 3569 Patients
    Zhang, H.
    Wang, W.
    Durm, G.
    Kesler, K.
    Kong, F. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E508 - E509
  • [23] Patient factors associated with survival in non-small cell lung cancer: An analysis of 846 patients from a single Institution.
    Zhao, Jing
    Patel, Vijay
    Hao, Zhonglin
    Dasher, Byron
    Ferguson, Catherine
    Davis, William
    Schroeder, Carsten
    Greenspan, Bennett
    Biddinger, Paul
    Kong, Feng-Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer A Comprehensive Analysis of 26,957 Patients with NSCLC
    Kawaguchi, Tomoya
    Takada, Minoru
    Kubo, Akihito
    Matsumura, Akihide
    Fukai, Shimao
    Tamura, Atsuhisa
    Saito, Ryusei
    Maruyama, Yosihito
    Kawahara, Masaaki
    Ignatius, Sai-Hong
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : 620 - 630
  • [25] Prognostic Factors for Overall Survival among Patients with Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Verleger, Katharina
    Treur, Maarten
    Penrod, John
    Daumont, Melinda
    Lees, Michael
    Macahilig, Cynthia
    Solem, Caitlyn
    Jiang, Shan
    Chirita, Oana
    Hertel, Nadine
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S995 - S996
  • [26] Octogenarians with Advanced Non-small Cell Lung Cancer Treatment Modalities, Survival, and Prognostic Factors
    Chen, Kuan-Yu
    Chen, Jen-Hau
    Shih, Jin-Yuan
    Yang, Chih-Hsin
    Yu, Chong-Jen
    Yang, Pan-Chyr
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (01) : 82 - 89
  • [27] The effect of chemotherapy on the tumor immune microenvironment in non-small cell lung cancer (NSCLC): A single-institution retrospective analysis.
    Devitt, Michael Edward
    Gade, Kristine E.
    Hall, Richard Delmar
    Horton, Bethany J.
    Stelow, Edward B.
    Bullock, Timothy
    Gentzler, Ryan D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [28] Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer A Single-Institution Experience of 144 Patients
    Gielda, Benjamin T.
    Marsh, James C.
    Zusag, Thomas W.
    Faber, L. Penfield
    Liptay, Michael
    Basu, Sanjib
    Warren, William H.
    Fidler, Mary Jo
    Batus, Marta
    Abrams, Ross A.
    Bonomi, Philip
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : 1079 - 1086
  • [29] Prognostic value of smoking status in operated non-small cell lung cancer
    Nia, PS
    Weyler, J
    Colpaert, C
    Vermeulen, P
    Van Marck, E
    Van Schil, P
    LUNG CANCER, 2005, 47 (03) : 351 - 359
  • [30] Prognostic factors for the survival of surgically treated patients for non-small cell lung cancer
    Fernandes, OJCB
    Almgren, SO
    Thaning, L
    Filbey, D
    Helsing, M
    Karlsson, M
    Magnusson, A
    Souza, D
    ACTA ONCOLOGICA, 2003, 42 (04) : 338 - 341